Charles River Laboratories | CRL - Net Income

Stock Price
188.70
Daily Change
-12.92 -6.41%
Monthly
-12.68%
Yearly
13.49%
Q1 Forecast
204.00

Charles River Laboratories reported $54.42M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Agilent USD 434M 98M Sep/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Bruker USD -62.4M 70M Sep/2025
Cardinal Health USD 467M 17M Dec/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Cigna USD 1.23B 55.22B Dec/2025
CVS Health USD -3.98B 5B Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Elevance Health USD 547M 642M Dec/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Humana USD 195M 350M Sep/2025
Illumina USD 150M 85M Sep/2025
Incyte USD 424.17M 19.17M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
Laboratory Of America USD 261.1M 23.2M Sep/2025
Lonza CHF 307M 22M Dec/2024
McKesson USD 1.19B 76M Dec/2025
Merck EUR 902M 250M Sep/2025
Mettler Toledo International USD 217.49M 15.14M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Quest Diagnostics USD 245M 37M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
United Therapeutics USD 338.7M 29.2M Sep/2025
UnitedHealth USD 10M 2.34B Dec/2025
Waters USD 148.92M 1.81M Sep/2025
West Pharmaceutical Services USD 140M 8.2M Sep/2025